Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

What goes up must come down: biomarkers and novel biologicals in severe asthma

(2015) B. Hilvering et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care

(2015) Merritt L. Fajt et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies

(2015) Kian Fan Chung   JOURNAL OF INTERNAL MEDICINE

Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE

(2015) Philip J. Lowe et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis

(2015) Astrid L. Voskamp et al.   Journal of Allergy and Clinical Immunology-In Practice

Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing table

(2014) Oliver Kornmann et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Exploring the Effects of Omalizumab in Allergic Asthma

(2013) Nicola A. Hanania et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A Proof-of-Concept, Randomized, Controlled Trial of Omalizumab in Patients With Severe, Difficult-to-Control, Nonatopic Asthma

(2013) Gilles Garcia et al.   CHEST

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

(2013) Marcus Maurer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reassessment of Omalizumab-Dosing Strategies and Pharmacodynamics in Inner-City Children and Adolescents

(2013) Christine A. Sorkness et al.   Journal of Allergy and Clinical Immunology-In Practice

Omalizumab Protects against Allergen- Induced Bronchoconstriction in Allergic (Immunoglobulin E-Mediated) Asthma

(2012) Stefan Zielen et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Asthma phenotypes: the evolution from clinical to molecular approaches

(2012) Sally E Wenzel   NATURE MEDICINE

Omalizumab: NICE to USE you, to LOSE you NICE

(2012) Andy Bush et al.   THORAX

Corticosteroid insensitivity in severe asthma: significance, mechanisms and aetiology

(2010) M. Hew et al.   INTERNAL MEDICINE JOURNAL

Safety and tolerability of omalizumab

(2009) J. Corren et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Inflammatory phenotypes in adult asthma: clinical applications

(2009) Peter Gerard Gibson   Clinical Respiratory Journal